Modern progestins in the treatment of endometriosis (a review)

Chernukha G.E.

doi:https://doi.org/

Chernukha G.E.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Modern progestins in the treatment of endometriosis (a review)

Authors:

Chernukha G.E.

More about the authors

Journal: Russian Journal of Human Reproduction. 2012;(4): 63‑66

Read: 16039 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Chernukha GE. Modern progestins in the treatment of endometriosis (a review). Russian Journal of Human Reproduction. 2012;(4):63‑66. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

References:

Giudice L.C. Endometriosis. N Engl J Med 2010; 362: 2389-2398.
Littman E., Giudice L., Lathi R., Berker B., Milki A., Nezhat C. Role of laparoscopic treatment of endometriosis inpatients with failed in vitro fertilization cycles. Fertil Steril 2005; 84: 1574-1578.
Guo S.W. Recurrence of endometriosis and its control. Hum Reprod Updare 2009; 15: 441-461.
Sagsveen M., Farmer J.E., Prentice A., Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis. Bone Min Dens 2003; 4: CD001297.
Küpker W., Felberbaum R.E., Krapp M., Schill T., Malik E., Diedrich K. Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online 2002; 5: 12-16.
Racine A.C., Legrand E., Lefebvre-Lacoeuille C. et al. Treatment of endometriosis by aromatase inhibitors: efficacy and side effects. Gynecol Obstet Fertil 2010; 38: 318-323.
Leyland N., Casper R., Laberge Ph., Singh S.S. et al. Endometriosis: diagnosis and management. SOGC Clinical and practical guideline. J Obstet Gynaecol (Canada) 2010; 32: 7: 1-28.
Management of endometriosis. Practical Bulletin No.114. The American College of Obstetricians and Gynecologists. Obstet Gynecol 2010; 116: 223-236.
Bulun S.E. Endometriosis. N Engl J Med 2009; 360: 268-279.
Sasagawa S., Shimizu Y., Kami H., Takeuchi T., Mita S., Imada K. et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008; 73: 222-231.
Klipping C., Duijkers I., Faustmann T.A. et al. Pharmacodynamic study of four oral dosages of dienogest. Fertil Steril 2010; 94: Suppl: S181.
Sitruk-Ware R. New progestagens for contraceptive use. Human Reprod Update 2006; 12: 2: 169-178.
Oettel M., Breitbarth H., Elger W. et al. The pharmacological profile of dienogest. Eur J Contracept Reprod Health Care 1999; 4: S1: 2-13.
Kohler G., Faustmann T.A., Gerlinger C. et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. Int J Gynecol Obstet 2010; 108: 21-25.
Strowitzki T., Faustmann T., Gerlinger C. et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010; 151: 193-198.
Cosson M., Querleu D., Donnez J. et al. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery:Results of a prospective, multicenter, randomized study. Fertil Steril 2002; 77: 4: 684-692.
Strowitzki T., Marr J., Gerlinger C., Faustmann T., Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: A 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010; 25: 3: 633-641.
Harada T., Momoeda M., Taketani Y. et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis - a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009; 91: 3: 675-681.
Barbieri R.L. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992; 166: 740-745.
Petraglia F., Hornung D., Seitz C. et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2011; 285: 1: 167-173.
Momoeda M., Harada T., Terakawa N. et al. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res 2009; 35: 6: 1069-1076.
Hughes E., Brown J., Collins J.J., Farquhar C., Fedorkow D.M., Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007; 3: CD000155.
Sallam H.N., Garcia-Velasco J.A., Dias S., Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006; 1: CD004635.
Moore C., Carol W., Graser T., Mellinger U., Walter F. Influence of dienogest on ovulation in young fertile women. Clin Drug Invest 1999; 18: 271-278.
Momoeda M., Taketani Y. Randomized double-blind, multicentre, parallel-group dose-response study of dienogest in patients with endometriosis. Jpn Pharmacol Ther 2007; 35: 769-783.